JP2010519311A5 - - Google Patents

Download PDF

Info

Publication number
JP2010519311A5
JP2010519311A5 JP2009550992A JP2009550992A JP2010519311A5 JP 2010519311 A5 JP2010519311 A5 JP 2010519311A5 JP 2009550992 A JP2009550992 A JP 2009550992A JP 2009550992 A JP2009550992 A JP 2009550992A JP 2010519311 A5 JP2010519311 A5 JP 2010519311A5
Authority
JP
Japan
Prior art keywords
acid
epimer
dtran
oil
ddan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009550992A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010519311A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/054456 external-priority patent/WO2008103753A2/en
Publication of JP2010519311A publication Critical patent/JP2010519311A/ja
Publication of JP2010519311A5 publication Critical patent/JP2010519311A5/ja
Pending legal-status Critical Current

Links

JP2009550992A 2007-02-20 2008-02-20 長鎖多価不飽和脂肪酸由来のオキシリピンならびにその作製およびその使用方法 Pending JP2010519311A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89070107P 2007-02-20 2007-02-20
PCT/US2008/054456 WO2008103753A2 (en) 2007-02-20 2008-02-20 Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same

Publications (2)

Publication Number Publication Date
JP2010519311A JP2010519311A (ja) 2010-06-03
JP2010519311A5 true JP2010519311A5 (enExample) 2011-04-07

Family

ID=39710725

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009550992A Pending JP2010519311A (ja) 2007-02-20 2008-02-20 長鎖多価不飽和脂肪酸由来のオキシリピンならびにその作製およびその使用方法

Country Status (5)

Country Link
US (1) US20110190389A1 (enExample)
EP (1) EP2120920A4 (enExample)
JP (1) JP2010519311A (enExample)
CN (1) CN101663031A (enExample)
WO (1) WO2008103753A2 (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8324277B2 (en) 2007-08-01 2012-12-04 University of Pittsburgh—of the Commonwealth System of Higher Education Nitrated-fatty acids modulation of type II diabetes
WO2009134383A2 (en) 2008-05-01 2009-11-05 Complexa Inc. Vinyl substituted fatty acids
US20140024713A1 (en) 2008-06-19 2014-01-23 University Of Utah Research Foundation Use of nitrated lipids for treatment of side effects of toxic medical therapies
EP2299997A4 (en) 2008-06-19 2012-01-11 Univ Utah Res Found USE OF NITRATED LIPIDS FOR THE TREATMENT OF SIDE EFFECTS OF TOXIC MEDICAL THERAPIES
EP3037401B1 (en) * 2008-09-16 2020-05-06 The Brigham And Women's Hospital Inc. 14-hydroxy-docosahexaenoic acid compounds
EP2415748A4 (en) 2009-02-20 2013-08-07 Univ Tokyo NEW INFLAMMATORY COMPOUNDS
FR2942964B1 (fr) * 2009-03-16 2012-08-17 Arkopharma Laboratoires Stimulateur metabolique des ppaps a base d'esters d'acides gras libres insatures, composition huileuse et complement alimentaire les contenant
EP2283839A1 (en) * 2009-06-30 2011-02-16 Institut National des Sciences Appliquées de Lyon Polyunsaturated hydroxylated molecule having an eze geometry and its use in therapy
EP3045167A1 (en) * 2009-07-31 2016-07-20 University of Pittsburgh - Of the Commonwealth System of Higher Education Keto fatty acids as anti-inflammatory agents
CA2781276A1 (en) 2009-10-02 2011-04-07 Complexa, Inc. Heteroatom containing substituted fatty acids
WO2013013211A1 (en) * 2011-07-21 2013-01-24 Dsm Ip Assets B.V. Fatty acid compositions
EP2744491B1 (en) 2011-08-19 2020-07-29 The University of Utah Research Foundation Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system
EP2760433B1 (en) * 2011-09-29 2023-05-31 PLx Opco Inc. pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME
CN107050457A (zh) 2012-01-06 2017-08-18 翁特拉制药公司 游离酸形式的ω‑3多不饱和脂肪酸的富含dpa组合物
CA2863765A1 (en) * 2012-02-03 2013-08-08 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Fatty acids as anti-inflammatory agents
JP6173352B2 (ja) * 2012-02-15 2017-08-02 アニダ ファーマ インコーポレイテッド 筋萎縮性側索硬化症の治療方法
EP2846779A4 (en) 2012-05-07 2015-12-16 Omthera Pharmaceuticals Inc STATIN AND OMEGA-3 FATTY ACID COMPOSITIONS
JP6370775B2 (ja) 2012-05-10 2018-08-08 ソルテックス エヌエー エルエルシー 天然の特異的炎症収束性メディエータおよびその前駆物質を含有する、抗炎症活性を有する油
WO2014032026A1 (en) 2012-08-24 2014-02-27 Mitra Ashim K Ophthalmic formulation of polyoxyl lipid or polyoxyl fatty acid and treatment of ocular conditions
HK1223551A1 (zh) * 2013-05-30 2017-08-04 The Brigham And Women's Hospital, Inc. 一种新颖的n-3 免疫溶剂：结构和动作
ES2810323T3 (es) * 2014-01-24 2021-03-08 Univ Kyoto Agente antiinflamatorio que contiene ácido graso raro
JP6315536B2 (ja) * 2014-01-29 2018-04-25 岩手県 Ｐｐａｒ活性化剤
WO2016057700A1 (en) * 2014-10-08 2016-04-14 The Brigham And Women's Hospital, Inc. Oxylipin-peptide conjugated mediators that promote resolution of infection, organ protection and tissue regeneration
BR112018000254A2 (pt) 2015-07-07 2018-09-04 H Lundbeck As inibidores de pde9 com cadeia principal de imidazotriazinona e cadeia principal de imidazopirazinona para o tratamento de doenças periféricas
HK1256301A1 (zh) * 2015-07-20 2019-09-20 The Brigham And Women's Hospital, Inc. 提高阿托伐他汀和清除感染的新的 13 系列消退素的说明
KR20170025977A (ko) * 2015-08-31 2017-03-08 재단법인차세대융합기술연구원 옥시리스 마리나로부터 분리된 신규 화합물
US10653703B2 (en) 2015-09-03 2020-05-19 Solutex Na Llc Compositions comprising omega-3 fatty acids, 17-HDHA and 18-HEPE and methods of using same
IL258476B2 (en) 2015-10-02 2023-04-01 Complexa Inc Prevention, treatment and reversal of disease using therapeutically effective amounts of activated fatty acids
PL3373976T3 (pl) 2015-11-10 2024-06-24 Sun Pharmaceutical Industries Limited Preparaty do stosowania miejscowego i ich zastosowanie
CN109563517A (zh) * 2016-06-01 2019-04-02 加拿大国家研究委员会 菟葵脂肪酸延伸酶及其在脂肪酸生产中的用途
CN111989399B (zh) * 2018-04-16 2024-07-12 韩国生命工学研究院 多不饱和脂肪酸的多羟基衍生物的制备方法
EP3801526B1 (en) 2018-05-25 2023-12-27 Imara Inc. Monohydrate and crystalline forms of 6-[(3s,4s)-4-methyl-1- (pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl- 7h-imid azo [1,5- a] pyrazin-8-one
CN112996512B (zh) 2018-08-31 2025-01-03 卡都瑞恩医药公司 用于治疗镰状细胞病的pde9抑制剂
CN109161576B (zh) * 2018-09-26 2020-08-07 武汉中科光谷绿色生物技术有限公司 促进枯草芽孢杆菌发酵生产n-乙酰神经氨酸的方法
KR102673270B1 (ko) * 2018-10-15 2024-06-07 (주)아모레퍼시픽 피부장벽 강화용 조성물
KR102704402B1 (ko) 2018-10-24 2024-09-06 (주)아모레퍼시픽 피부장벽 강화용 조성물
TW202523283A (zh) * 2019-10-25 2025-06-16 美商努賽德營養美國股份有限公司 富集的多元不飽和脂肪酸組成物
WO2021166998A1 (ja) * 2020-02-18 2021-08-26 国立大学法人北海道大学 レゾルビンｅ２の安定等価体
KR20220159751A (ko) 2021-05-26 2022-12-05 (주)아모레퍼시픽 미백용 조성물 및 이를 이용한 피부 미백방법
JPWO2023090313A1 (enExample) * 2021-11-16 2023-05-25
CN114354785B (zh) * 2021-12-22 2023-06-27 中国农业科学院油料作物研究所 一种基于保留指数结合化学衍生化质谱特征二级碎片的氧脂素综合定性方法
WO2024108603A1 (zh) * 2022-11-25 2024-05-30 中国科学院深圳先进技术研究院 基于粪便代谢物的神经退行性疾病标志物及其应用
FR3148365A1 (fr) * 2023-05-04 2024-11-08 Pierre Fabre Dermo-Cosmetique Oxylipines dans le traitement de la séborrhée et/ou de l’acné
CN121027545B (zh) * 2025-10-31 2026-02-03 华中科技大学同济医学院附属协和医院 甲状腺相关眼病的负离子代谢标志物、产品及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4866046A (en) * 1988-05-31 1989-09-12 Top Laboratories, Inc. Low-dosage sublingual aspirin
US5102670A (en) * 1990-09-14 1992-04-07 Abraham Nader G Method for treating eye disorders by reducing 12(r)-hydroxyeicosatetraenoic acid and 12(r)-dihydroxyeicosatrienoic acid levels
US20050027004A1 (en) * 1993-06-09 2005-02-03 Martek Biosciences Corporation Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
US6887901B1 (en) * 1993-06-15 2005-05-03 Brigham & Women's Hospital, Inc. Lipoxin compounds and their use in treating cell proliferative disorders
GB9403857D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
US5955496A (en) * 1996-08-13 1999-09-21 The Regents Of The University Of California Dihydroxy-oxy-eicosadienoates
JP4151853B2 (ja) * 1996-10-11 2008-09-17 スカリスタ リミテッド エイコサペンタエン酸および／またはステアリドン酸を含む治療用薬剤
US6174695B1 (en) * 1997-08-12 2001-01-16 The Regents Of The University Of California Epoxide hydrolase inhibitor methods
DE19757414A1 (de) * 1997-12-23 1999-07-01 Nutricia Nv Fettmischung
DE60034775T3 (de) * 1999-03-04 2016-11-24 Suntory Holdings Ltd. Verwendung von Docosapentsäure enthaltendem Material
AU5850000A (en) * 1999-07-07 2001-01-30 Kyowa Hakko Kogyo Co. Ltd. Process for producing hydroxylated fatty acid and delta-lactone
EP1762557B1 (en) * 2000-02-16 2011-04-06 The Brigham And Women's Hospital, Inc. Aspirin-triggered lipid mediators
DE10046541A1 (de) * 2000-09-19 2002-03-28 Knoll Ag Mechanisch stabile darreichungsformen, enthaltend Ubichinone
WO2002029018A2 (en) * 2000-10-06 2002-04-11 Michigan State University Divinyl ether synthase gene and protein, and uses thereof
AU2002309856B2 (en) * 2001-05-14 2008-10-23 Dsm Ip Assets B.V. Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms
US7527935B2 (en) * 2002-03-19 2009-05-05 Mitsubishi Tanabe Pharma Corporation G-protein coupled receptor having eicosanoid as ligand and gene thereof
WO2003084305A2 (en) * 2002-04-01 2003-10-16 University Of Southern California Trihydroxy polyunsaturated eicosanoids
US7582785B2 (en) * 2002-04-01 2009-09-01 University Of Southern California Trihydroxy polyunsaturated eicosanoid derivatives
FR2843124B1 (fr) * 2002-08-02 2004-10-15 Goemar Lab Sa Procede de preparation d'acides gras polyinsatures libres et de leurs metabolites d'oxydation
AU2003258194B2 (en) * 2002-08-12 2009-11-12 The Brigham And Women's Hospital, Inc. Resolvins: biotemplates for therapeutic interventions
US20040166130A1 (en) * 2002-12-23 2004-08-26 L'oreal Lanolin-free cosmetic composition comprising a hydroxylated fatty acid aromatic ester
JP2008520739A (ja) * 2004-11-19 2008-06-19 マーテック・バイオサイエンシーズ・コーポレーション 長鎖多価不飽和脂肪酸由来のオキシリピンならびにその作製および使用方法
US7893106B2 (en) * 2004-11-19 2011-02-22 Martek Biosciences, Corporation Oxylipins from stearidonic acid and γ-linolenic acid and methods of making and using the same

Similar Documents

Publication Publication Date Title
JP2008520739A5 (enExample)
US7884131B2 (en) Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
US7893106B2 (en) Oxylipins from stearidonic acid and γ-linolenic acid and methods of making and using the same
JP2010519311A (ja) 長鎖多価不飽和脂肪酸由来のオキシリピンならびにその作製およびその使用方法
DE60124256T3 (de) Aspirin-ausgelöste lipidmediatoren
JP2010532418A5 (enExample)
KR102373368B1 (ko) 효소를 이용한 고농도 팔미톨레산 함유 트리글리세라이드 제조방법
JP7242769B2 (ja) 遊離多価不飽和脂肪酸含有組成物及びその製造方法
JP2009519032A (ja) ドコサヘキサエン酸（ｄｈａ）産生スラウストキトリウム菌株‐ｓｃ１
EP1983977A2 (en) Oxylipins from stearidonic acid and gamma-linolenic acid and methods of making and using the same
JP6715586B2 (ja) 高度不飽和脂肪酸の製造方法
AU743992B2 (en) Process for producing omega-9 highly unsaturated fatty acid and lipid containing the same
JPWO2006022356A1 (ja) ジアシルグリセロールの含量を任意に含んだ微生物油脂の製造法並びに該油脂
JPWO2019208803A1 (ja) 微生物油及び微生物油の製造方法
JP3931219B2 (ja) 高度不飽和脂肪酸含有油脂の製造方法
JP2001245688A (ja) ５，１１，１４−エイコサトリエン酸及び／又は５，１１，１４，１７−エイコサテトラエン酸を含有する脂質及びその製造方法
JP2010094111A (ja) 高度不飽和脂肪酸の製造方法
KR100900030B1 (ko) 고순도 불포화 지방산의 제조방법
JP3544247B2 (ja) 血小板凝集能抑制用薬剤組成物
AU2011253846A1 (en) Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
JP2007089522A (ja) 特定の高度不飽和脂肪酸が濃縮された脂肪酸組成物の製造方法
AU2023329693B2 (en) Cetoleic acid composition
JP2006061021A (ja) １種類の高度不飽和脂肪酸残基３個から成るトリグリセライドの製造方法、およびその利用
JPH0319694A (ja) ドコサヘキサエン酸グリセリドの濃縮法
US20110027841A1 (en) Method for preparation of oxylipins